Pancreatic Cancer Research

ResearcherUniversity of the WitwatersrandActive in the last 2 years

Geoffrey Patrick Candy

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5449-1277; OpenAlex author ID A5090495800. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2020: 4 papers · 2021: 2 papers · 2022: none · 2023: none · 2024: 3 papers · 2025: none · 2026: 1 paper

Papers 10

  1. Proteomic Profiling of Extracellular Vesicle-Enriched Plasma Using Mag-Net for Biomarker Discovery in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1021/acs.jproteome.6c00172↗
  2. The combination ofSPP1knockdown and gemcitabine treatment enhances apoptosis and reduces invasiveness of pancreatic cancer cells Co-author DOI 10.1101/2024.05.05.24306611↗
  3. Comparative immune profiling of pancreatic ductal adenocarcinoma progression among South African patients. Co-author DOI 10.1186/s12885-024-12595-x↗
  4. Inhibition of the Complement Pathway Induces Cellular Proliferation and Migration in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.23812/j.biol.regul.homeost.agents.20243802.94↗
  5. Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance. First author DOI 10.3389/fonc.2021.683788↗
  6. Serum Metabolomic and Lipoprotein Profiling of Pancreatic Ductal Adenocarcinoma Patients of African Ancestry. Co-author DOI 10.3390/metabo11100663↗
  7. Immunotherapeutic strategies in pancreatic ductal adenocarcinoma (PDAC): current perspectives and future prospects. First author DOI 10.1007/s11033-020-05648-4↗
  8. SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular… Last author DOI 10.1371/journal.pone.0240453↗
  9. Role of different immune cells and metabolic pathways in modulating the immune response in pancreatic cancer (Review). Co-author DOI 10.3892/mmr.2020.11622↗
  10. Increased expression of plakoglobin is associated with upregulated MAPK and PI3K/AKT signalling pathways in early resectable pancreatic ductal adenocarcinoma. Last author DOI 10.3892/ol.2020.11473↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ekene Emmanuel Nweke · 10 shared papers, 2020–2026 · strength 1.72
  2. Martin Smith · 8 shared papers, 2020–2024 · strength 1.33
  3. Nnenna Elebo · 4 shared papers, 2020–2026 · strength 0.72
  4. Zanele Nsingwane · 3 shared papers, 2020–2024 · strength 0.57
  5. Ntombikayise Xelwa · 2 shared papers, 2021–2024 · strength 0.39
  6. Pascaline Fru · 2 shared papers, 2020–2024 · strength 0.35
  7. Sindisiwe G. Buthelezi · 1 shared paper, 2026 · strength 0.24
  8. Martin Brand · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.